IGFBP3 and lung carcinoma: For lung cancer, the findings of the current study are consistent with our meta-analysis (Renehan et al, 2004) that reported no association with circulating IGF-I but a significant inverse association with IGFBP-3 (after excluding a heavy smokers-only study).